GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (HKSE:01696) » Definitions » Long-Term Capital Lease Obligation

Sisram Medical (HKSE:01696) Long-Term Capital Lease Obligation : HK$264 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sisram Medical Long-Term Capital Lease Obligation?

Sisram Medical's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$264 Mil.

Sisram Medical's quarterly Long-Term Capital Lease Obligation declined from Dec. 2023 (HK$278 Mil) to Jun. 2024 (HK$273 Mil) and declined from Jun. 2024 (HK$273 Mil) to Dec. 2024 (HK$264 Mil).

Sisram Medical's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (HK$255 Mil) to Dec. 2023 (HK$278 Mil) but then declined from Dec. 2023 (HK$278 Mil) to Dec. 2024 (HK$264 Mil).


Sisram Medical Long-Term Capital Lease Obligation Historical Data

The historical data trend for Sisram Medical's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sisram Medical Long-Term Capital Lease Obligation Chart

Sisram Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 252.31 243.60 254.72 277.59 264.28

Sisram Medical Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 254.72 272.49 277.59 272.64 264.28

Sisram Medical  (HKSE:01696) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Sisram Medical Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sisram Medical's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Sisram Medical Business Description

Traded in Other Exchanges
N/A
Address
HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices, and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Executives
Fosun Holdings Limited
Fosun International Holdings Ltd.
Fosun International Limited
Guo Guangchang
Ample Up Limited
Fosun Industrial Co., Limited
Shanghai Fosun High Technology (group) Co., Ltd.
Shanghai Fosun Pharmaceutical (group) Co., Ltd.
Chindex Medical Limited

Sisram Medical Headlines

No Headlines